Springer Regulation of Agricultural Biotechnology: The United States and Canada

Product Description Written in a practical, didactic format designed to deliver point-of-care information to practitioners of cardiology as well as assist non-cardiologists with the efficient management of cardiac disease, this highly illustrated manual is an essential reference. Review From the reviews: “This book describes the history and scope of North American agricultural biotechnology concerns, laws, and policies. Each of the 17 chapters is written by an authority on the topic and contains highly relevant primary source references. … the book explores global regulatory perspectives on biotechnology products and the influence of public sector research on agricultural biotechnology. The text is well written, and the information provided is free from bias. Summing Up: Recommended. All academic and professional public policy, science law, and bioethics library collections.” (B. R. Shmaefsky, Choice, Vol. 50 (9), May, 2013) From the Back Cover Chris Wozniak brings 24 years of experience working with USDA and EPA while Alan McHughen brings over 26 years of working with transgenic organisms as an academic scientist in Canada and USA. Together they compiled a series of chapters from experts from industry, academia and government to explain how the regulations arose, what they are today and how they need to change to keep up with the rapidly evolving technology to assure product safety while not unduly impeding the potential benefits of this powerful technology. What was the impetus for regulating biotechnology while other methods of genetic modification remain exempted from premarket safety assessments? How were the regulations made? How are they enforced? How do the diverse political agendas meld with the scientific foundation in assessing safety? How does the perspective of the technology developer differ from that of the biosafety regulator?  In addressing these questions and others, this book offers authoritative and comprehensive yet accessible and illuminating insights into the agricultural biotech regulatory systems in both countries.